Accessibility Menu
GoodRx Stock Quote

GoodRx (NASDAQ: GDRX)

$3.11
(-1.7%)
-0.06
Price as of November 7, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$3.11
Daily Change
(-1.7%) $0.06
Day's Range
$2.96 - $3.13
Previous Close
$3.11
Open
$3.10
Beta
1.73
Volume
3,483,135
Average Volume
4,927,198
Market Cap
1.1B
Market Cap / Employee
$3.11M
52wk Range
$2.96 - $5.81
Revenue
-
Gross Margin
0.83%
Dividend Yield
N/A
EPS
$0.09
CAPs Rating
-
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

GoodRx Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
GDRX-38.29%-93.81%-42.64%-94%
S&P+12.65%+91.73%+13.89%+108%

GoodRx Company Info

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2015 and is headquartered in Santa Monica, CA.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$196.03M0.4%
Gross Profit$161.18M-2.9%
Gross Margin82.22%-2.8%
Market Cap$1.47B-44.2%
Market Cap / Employee$1.99M0.0%
Employees7386.3%
Net Income$1.12M-71.8%
EBITDA$47.85M25.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$273.53M-35.5%
Accounts Receivable$203.74M55.8%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$535.37M0.0%
Short Term Debt$9.76M5.0%

Ratios

Q3 2025YOY Change
Return On Assets2.37%3.4%
Return On Invested Capital-4.81%-2.2%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$74.28M-14.1%
Operating Free Cash Flow$76.02M-12.5%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Earnings109.1559.3553.6649.24-
Price to Book2.542.332.752.32-38.85%
Price to Sales2.252.102.221.84-46.13%
Price to Tangible Book Value15.8512.3253.3385.47261.27%
Price to Free Cash Flow TTM9.7711.189.398.30-52.75%
Enterprise Value to EBITDA40.9538.3343.1136.42-50.86%
Free Cash Flow Yield10.2%8.9%10.7%12.1%111.66%
Return on Equity2.2%4.4%5.3%4.9%-338.13%
Total Debt$543.39M$541.19M$547.54M$545.14M0.10%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.